Clinical Trials
4 trialsNCT05065411 2024-02-26
VERU-024
Veru Inc.
Phase 3 Terminated
NCT04869943 2024-01-26
ARTEST
Veru Inc.
Phase 3 Terminated
NCT01355497 2020-11-09
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
GTx
Phase 3 Completed
NCT01355484 2016-03-03
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
GTx
Phase 3 Completed